The serine kinases IKK2 and JNK1 contribute to insulin resistance by phosphorylation of IRS-1. This activity has been widely used to explain insulin resistance for many risk factors including inflammation, lipotoxicity, ER stress and oxidative stress. Our study in the last funding period suggests that S6K and HDACs are targeted by the two serine kinases in the regulation of glucose and lipid metabolism. Our data suggests that IKK2 and JNK1 signals may be integrated in the S6K1 activation in the cytoplasm for IRS-1 inhibition. Their signals may also be combined in the regulation of PPARg activity in the nucleus through HDACs. Based on these observations, we hypothesize that S6K1 and HDACs may mediate signals of IKK2 and JNK1 in the regulation of glucose and lipid metabolism. However, the hypothesis remains to be tested and the details remain to be uncovered. We will address these issues in two specific aims:
AIM I : To test that the IKK2-JNK1 signal integration may lead to S6K activation in the cytoplasm;
AIM II : To test that the IKK2-JNK1 signal integration may control HDACs function in the nucleus. The results will provide a novel and unified mechanism for IKK2 and JNK1 in the regulation of glucose and fatty acid metabolism. The study may lead to identification of new drug target in prevention and treatment of metabolic syndrome.

Public Health Relevance

Type 2 diabetes has been a major health threat to the general public in US. The treatment and prevention of the disease is limited by our understanding of the molecular mechanism of the diseases. In this study, we will investigate the molecular mechanism by focusing on two molecules IKK2 and JNK1. The study will help us to understand the molecular mechanisms, and to identify new drug target for type 2 diabetes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK068036-09
Application #
8534760
Study Section
Cellular Aspects of Diabetes and Obesity Study Section (CADO)
Program Officer
Abraham, Kristin M
Project Start
2004-06-01
Project End
2014-08-31
Budget Start
2013-09-01
Budget End
2014-08-31
Support Year
9
Fiscal Year
2013
Total Cost
$293,388
Indirect Cost
$95,153
Name
Lsu Pennington Biomedical Research Center
Department
Type
Organized Research Units
DUNS #
611012324
City
Baton Rouge
State
LA
Country
United States
Zip Code
70808
Xu, Fen; Zheng, Xiaobin; Lin, Beisi et al. (2016) Diet-induced obesity and insulin resistance are associated with brown fat degeneration in SIRT1-deficient mice. Obesity (Silver Spring) 24:634-42
Sun, Jingquan; Ye, Xin; Xie, Minhao et al. (2016) Induction of triglyceride accumulation and mitochondrial maintenance in muscle cells by lactate. Sci Rep 6:33732
Mumphrey, M B; Hao, Z; Townsend, R L et al. (2016) Eating in mice with gastric bypass surgery causes exaggerated activation of brainstem anorexia circuit. Int J Obes (Lond) 40:921-8
Lu, H; Gao, Z; Zhao, Z et al. (2016) Transient hypoxia reprograms differentiating adipocytes for enhanced insulin sensitivity and triglyceride accumulation. Int J Obes (Lond) 40:121-8
Zhang, Yong; Zhao, Zhiyun; Ke, Bilun et al. (2016) Induction of Posttranslational Modifications of Mitochondrial Proteins by ATP Contributes to Negative Regulation of Mitochondrial Function. PLoS One 11:e0150454
Karkeni, Esma; Astier, Julien; Tourniaire, Franck et al. (2016) Obesity-associated Inflammation Induces microRNA-155 Expression in Adipocytes and Adipose Tissue: Outcome on Adipocyte Function. J Clin Endocrinol Metab 101:1615-26
Hao, Z; Münzberg, H; Rezai-Zadeh, K et al. (2015) Leptin deficient ob/ob mice and diet-induced obese mice responded differently to Roux-en-Y bypass surgery. Int J Obes (Lond) 39:798-805
Zhou, Jiaqiang; Hao, Zheng; Irwin, Nigel et al. (2015) Gastric inhibitory polypeptide (GIP) is selectively decreased in the roux-limb of dietary obese mice after RYGB surgery. PLoS One 10:e0134728
Ye, Jianping (2015) Beneficial metabolic activities of inflammatory cytokine interleukin 15 in obesity and type 2 diabetes. Front Med 9:139-45
Goldsmith, Felicia; Keenan, Michael J; Raggio, Anne M et al. (2015) Induction of Energy Expenditure by Sitagliptin Is Dependent on GLP-1 Receptor. PLoS One 10:e0126177

Showing the most recent 10 out of 57 publications